RankingsPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. D/E ratio (%)

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥40.8B
P/E ratio
17.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndD/E ratio (%) (Million JPY)YoY (%)
May 31, 202518.6+43.39%
May 31, 202412.9+37.60%
May 31, 20239.4+30.58%
May 31, 20227.2-10.63%
May 31, 20218.1-3.89%
May 31, 20208.4-46.81%
May 31, 201915.8-39.12%
May 31, 201825.9-21.30%
May 31, 201732.9-22.07%
May 31, 201642.3+3.09%
May 31, 201541

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)